Publication: Diabetic osteodystrophy
dc.contributor.author | Eren, Mehmet Ali | |
dc.contributor.author | Gül, Özen Öz | |
dc.contributor.buuauthor | ÖZ GÜL, ÖZEN | |
dc.contributor.department | Tıp Fakültesi | |
dc.contributor.department | Endokrinoloji Anabilim Dalı | |
dc.contributor.researcherid | KXW-8889-2024 | |
dc.date.accessioned | 2025-02-06T06:40:22Z | |
dc.date.available | 2025-02-06T06:40:22Z | |
dc.date.issued | 2024-07-01 | |
dc.description.abstract | Diabetes mellitus (DM) is associated with an increased risk of fractures due to deterioration of bone quality, which can be referred to as "diabetic osteodystrophy." Furthermore, the risk of fracture is increased in DM, even if bone mineral density is normal or high and is associated with increased morbidity if a fracture develops. In addition to the pathophysiological mechanisms of DM, diabetes- related complications and drugs used in the treatment of DM may also affect bone health. Moreover, the increased risk of falling due to microvascular complications, hypoglycemia, and postural hypotension also contributes to the development of fractures. Individuals with DM should be screened for osteoporosis with recommendations similar to those of the general population. When diagnosing osteoporosis and deciding on treatment, it should be kept in mind that DM may be an important risk factor, and lower threshold values of the T score should be used. | |
dc.identifier.doi | 10.5152/erp.2024.24463 | |
dc.identifier.eissn | 2822-6135 | |
dc.identifier.endpage | 180 | |
dc.identifier.issue | 3 | |
dc.identifier.scopus | 2-s2.0-85199174325 | |
dc.identifier.startpage | 175 | |
dc.identifier.uri | https://doi.org/10.5152/erp.2024.24463 | |
dc.identifier.uri | https://endocrinolrespract.org/en/diabetic-osteodystrophy-131225 | |
dc.identifier.uri | https://hdl.handle.net/11452/50147 | |
dc.identifier.volume | 28 | |
dc.identifier.wos | 001267516900008 | |
dc.indexed.wos | WOS.ESCI | |
dc.language.iso | en | |
dc.publisher | Aves Yayıncılık | |
dc.relation.journal | Endocrinology Research and Practice | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Bone-mineral density | |
dc.subject | Dipeptidyl peptidase-4 inhibitors | |
dc.subject | Glycation end-products | |
dc.subject | Insulin-resistance | |
dc.subject | Fracture risk | |
dc.subject | Metaanalysis | |
dc.subject | Turnover | |
dc.subject | Association | |
dc.subject | Mellitus | |
dc.subject | Disease | |
dc.subject | Diabetes mellitus | |
dc.subject | Fracture risk | |
dc.subject | Osteodystrophy | |
dc.subject | Osteoporosis | |
dc.subject | Science & technology | |
dc.subject | Life sciences & biomedicine | |
dc.subject | Endocrinology & metabolism | |
dc.title | Diabetic osteodystrophy | |
dc.type | Review | |
dspace.entity.type | Publication | |
local.contributor.department | Tıp Fakültesi/Endokrinoloji Anabilim Dalı | |
local.indexed.at | WOS | |
local.indexed.at | Scopus | |
relation.isAuthorOfPublication | 4ebb27f5-06de-45b8-8773-ea3452507df3 | |
relation.isAuthorOfPublication.latestForDiscovery | 4ebb27f5-06de-45b8-8773-ea3452507df3 |
Files
Original bundle
1 - 1 of 1